Correlation Between Denali Therapeutics and Cyclerion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Cyclerion Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Cyclerion Therapeutics.
Diversification Opportunities for Denali Therapeutics and Cyclerion Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Denali and Cyclerion is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Cyclerion Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Cyclerion Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 12.77 times less return on investment than Cyclerion Therapeutics. But when comparing it to its historical volatility, Denali Therapeutics is 4.04 times less risky than Cyclerion Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Cyclerion Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,598 in Cyclerion Therapeutics on November 2, 2024 and sell it today you would lose (1,344) from holding Cyclerion Therapeutics or give up 84.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Denali Therapeutics vs. Cyclerion Therapeutics
Performance |
| Timeline |
| Denali Therapeutics |
| Cyclerion Therapeutics |
Denali Therapeutics and Cyclerion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Cyclerion Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Cyclerion Therapeutics vs. Kronos Bio | Cyclerion Therapeutics vs. Larimar Therapeutics | Cyclerion Therapeutics vs. Addex Therapeutics | Cyclerion Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |